Showing 71-80 of 334 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Prohormone convertase activity in human T1D pancreas tissue slices | University of Florida | Denise Drotar | Cures | 01-March-2025 to 29-February-2028 | $264,895.00 |
| Engineering Bioactive Retrievable 3D Scaffolds for Improving Islet Transplantation | University of Florida | Cherie Stabler | Cures | 01-February-2021 to 31-January-2025 | $698,170.00 |
| Combinational immune therapies with antigen-specific Tregs for tolerance induction in islet transplantation | University of Florida | Allison Bayer | Cures | 01-September-2023 to 30-September-2025 | $510,297.39 |
| Charting a Path for Continuous Insulin Monitoring | University of Cincinnati | Ryan White | Improving Lives | 01-April-2024 to 31-March-2027 | $708,147.00 |
| Treatment of type-1 diabetes with apolipoprotein A4 – efficacy and mechanisms | University of Cincinnati | Min Liu | Cures | 01-March-2023 to 28-February-2026 | $721,291.00 |
| Development of a Microfluidic Patch Pump for Next-Generation Wearable Artificial Pancreas Systems | University of California, Santa Barbara | Sumita Pennathur | Improving Lives | 01-May-2023 to 30-April-2026 | $1,065,254.36 |
| Reducing the Burden of Type 1 Diabetes Using Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances | University of California, San Diego | Schafer Boeder | Improving Lives | 01-July-2022 to 30-June-2027 | $749,956.58 |
| Microneedle Sensor for Simultaneous Continuous Monitoring of Ketone and Glucose | University of California, San Diego | Joseph Wang | Improving Lives | 01-October-2022 to 30-September-2025 | $799,998.91 |
| The Effects of Glucagon Antagonism on Insulin Resistance, Ketone Production, and Cardiovascular Risk in Individuals with Type 1 Diabetes | University of California, San Diego | Jeremy Pettus | Improving Lives | 01-June-2021 to 30-November-2025 | $1,063,576.00 |
| Acetazolamide and Tubuloglomerular Feedback in Persons with Type 1 Diabetes: A Clinical Trial | University of California, San Diego | Charles Ginsberg | Improving Lives | 01-November-2022 to 31-October-2026 | $1,356,726.45 |